Journal Article

Sacituzumab govitecan: a new antibody–drug conjugate for metastatic triple-negative breast cancer

Onkologe (2021) 27(3) 287-290
DOI: 10.1007/s00761-021-00899-7
1Citations
Citations of this article
1Readers
Mendeley users who have this article in their library.
Get full text

Cite

CITATION STYLE

APA

Banys-Paluchowski, M., & Krawczyk, N. (2021). Sacituzumab govitecan: a new antibody–drug conjugate for metastatic triple-negative breast cancer. Onkologe, 27(3), 287–290. https://doi.org/10.1007/s00761-021-00899-7

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free